18 participants
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-05-05
- Start Date:
- 2008-09-30
- Completion:
- 2009-08-31
Conditions
- Pancreatic Cancer
Interventions
- DRUG
No Results Yet